Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 47 min ago
Peer-reviewedCC BY 4.0Pathology International

Primary Small Cell Carcinoma of the Thyroid With Absent Calcitonin Expression: A Diagnostic Challenge

6 affiliations
  1. 1Department of Pathology Unidade Local de Saúde (ULS) São João (CHUSJ) Porto Portugal
  2. 2Faculty of Medicine of the University of Porto (FMUP) Porto Portugal
  3. 3General Surgery Department Unidade Local de Saúde (ULS) São João (CHUSJ) Porto Portugal
  4. 4Endocrinology Department Unidade Local de Saúde (ULS) São João (CHUSJ), ENDO‐ERN Porto Portugal
  5. 5Ipatimup (Institute of Molecular Pathology and Immunology of the University of Porto) Porto Portugal
  6. 6Department of Pathology, Clinical University Hospital of Santiago de Compostela, Galician Healthcare Service (SERGAS) Health Research Institute of Santiago de Compostela (IDIS), Medical Faculty, University of Santiago de Compostela Santiago de Compostela Spain

Abstract

Primary small cell carcinoma of the thyroid is an exceedingly rare and aggressive neuroendocrine malignancy. Diagnosis may be particularly challenging in tumors lacking calcitonin expression, in which distinction from medullary thyroid carcinoma and metastatic neuroendocrine carcinomas is required. A 50‐year‐old woman presented with progressive hoarseness and a rapidly enlarging cervical mass. Imaging revealed a highly infiltrative thyroid tumor with multiple cervical lymphadenopathies and no evidence of a primary tumor elsewhere. Serum calcitonin levels were within normal limits. Fine‐needle aspiration biopsy of the thyroid lesion and a cervical lymph node demonstrated cytologic features consistent with small cell carcinoma. Following a good response to neoadjuvant chemotherapy, total thyroidectomy with central, bilateral mediastinal lymphadenectomy was performed. Histologic examination demonstrated a highly infiltrative neoplasm composed of small cells arranged in solid and nested patterns with marked mitotic activity, tumor necrosis, and vascular and perineural invasion. Tumor cells expressed neuroendocrine markers with focal positivity for TTF‐1/NKX2‐1 and CEA, while calcitonin, thyroglobulin, PAX8, and CGRP were negative. Primary thyroid small cell carcinoma is exceptionally rare and its histogenesis remains uncertain. Diagnosis requires careful clinicopathologic correlation and exclusion of metastatic disease and calcitonin‐negative variants of medullary thyroid carcinoma.

Related

  1. Diagnostic challenge in distinguishing intestinal endometriosis-associated carcinoma from primary colorectal adenocarcinoma: a case report
    Norie Tojo, Hisashi Kataoka, Yuko Izumi +2
    Journal of Surgical Case ReportsPeer-reviewedCC BY-NC 4.0Full textObstetrics, gynaecology & paediatricsPMC
  2. Diagnostic challenge of pulmonary embolism during testosterone replacement therapy for primary hypogonadism
    JCEM case reportsPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  3. Giant primary retroperitoneal myxofibrosarcoma mimicking myxoid liposarcoma: a diagnostic and surgical challenge
    Journal of surgical case reportsPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Diagnostic Challenge in Cytology: Fibrosing Thyroiditis Mimicking Medullary Thyroid Carcinoma.
    G Anju, Meenakshi Rao, Nivedita Sharma
    Journal of cytologyPeer-reviewedCC BY-NC-SAFull textEndocrinology & metabolismEurope PMC
  5. Diagnostic Challenge of Primary Hepatic PEComa in a Young Woman with Prior Colorectal Cancer
    Gerald Odong, Priyanka Panwar, Lavender Otom +8
    ACG Case Reports JournalPeer-reviewedCC BY 4.0Full textHuman geneticsPMC
BibTeX
@article{almeida2026primary,
  title = {{Primary Small Cell Carcinoma of the Thyroid With Absent Calcitonin Expression: A Diagnostic Challenge}},
  author = {João Carlos Almeida and Patrícia Andrea‐Ferreira and Catarina Costa and Pedro Amoroso Canão and Elisabete Rodrigues and Manuel Sobrinho‐Simões and José Manuel Cameselle‐Teijeiro},
  journal = {Pathology International},
  year = {2026},
  month = nov,
  doi = {10.1111/pin.70204},
  url = {https://doi.org/10.1111/pin.70204},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Primary Small Cell Carcinoma of the Thyroid With Absent Calcitonin Expression: A Diagnostic Challenge
AU  - João Carlos Almeida
AU  - Patrícia Andrea‐Ferreira
AU  - Catarina Costa
AU  - Pedro Amoroso Canão
AU  - Elisabete Rodrigues
AU  - Manuel Sobrinho‐Simões
AU  - José Manuel Cameselle‐Teijeiro
PY  - 2026
DA  - 2026/11/09
JO  - Pathology International
DO  - 10.1111/pin.70204
UR  - https://doi.org/10.1111/pin.70204
AB  - Primary small cell carcinoma of the thyroid is an exceedingly rare and aggressive neuroendocrine malignancy. Diagnosis may be particularly challenging in tumors lacking calcitonin expression, in which distinction from medullary thyroid carcinoma and metastatic neuroendocrine carcinomas is required. A 50‐year‐old woman presented with progressive hoarseness and a rapidly enlarging cervical mass. Imaging revealed a highly infiltrative thyroid tumor with multiple cervical lymphadenopathies and no evidence of a primary tumor elsewhere. Serum calcitonin levels were within normal limits. Fine‐needle aspiration biopsy of the thyroid lesion and a cervical lymph node demonstrated cytologic features consistent with small cell carcinoma. Following a good response to neoadjuvant chemotherapy, total thyroidectomy with central, bilateral mediastinal lymphadenectomy was performed. Histologic examination demonstrated a highly infiltrative neoplasm composed of small cells arranged in solid and nested patterns with marked mitotic activity, tumor necrosis, and vascular and perineural invasion. Tumor cells expressed neuroendocrine markers with focal positivity for TTF‐1/NKX2‐1 and CEA, while calcitonin, thyroglobulin, PAX8, and CGRP were negative. Primary thyroid small cell carcinoma is exceptionally rare and its histogenesis remains uncertain. Diagnosis requires careful clinicopathologic correlation and exclusion of metastatic disease and calcitonin‐negative variants of medullary thyroid carcinoma.
SN  - 1320-5463
SN  - 1440-1827
ER  -